1. Butylphthalide is effective the BAST trial showed that butylphthalide is associated with more favorable functional outcomes compared to placebo in patients who underwent reperfusion therapy for acute ischemic stroke. 2. Butylphthalide is safe – the treatment and placebo group had similar incidences of serious adverse outcomes (death, symptomatic intracranial hemorrhage and other side
Butylphthalide, a new medication that comes from celery seed, could improve outcomes after a clot-caused stroke when given in addition to prompt treatment for the clot, according to a new study.